The rapid flow of studies in the field of cancer and immunology during the last decades has increased our understanding of the interactions between the immune system and cancerous cells. In particular, it has been well-known that such interactions result in the induction of epigenetic changes in cancerous cells and the selection of less immunogenic clones as well as alterations in immune responses. Understanding the crosstalk between nascent transformed cells and cells of the immune system has led to the development of combinatorial immunotherapeutic strategies to combat cancer. The…mehr
The rapid flow of studies in the field of cancer and immunology during the last decades has increased our understanding of the interactions between the immune system and cancerous cells. In particular, it has been well-known that such interactions result in the induction of epigenetic changes in cancerous cells and the selection of less immunogenic clones as well as alterations in immune responses. Understanding the crosstalk between nascent transformed cells and cells of the immune system has led to the development of combinatorial immunotherapeutic strategies to combat cancer.
The Handbook of Cancer and Immunology offers a comprehensive and up-to-date review of cancer immunology and immunotherapy, emphasizing key findings and clinically relevant data. This reference work is an essential resource for researchers, students, academics, and clinicians committed to advancing knowledge, diagnostics, and treatments in this vital field.
Artikelnr. des Verlages: 89569068, 978-3-032-00766-7
Seitenzahl: 1090
Erscheinungstermin: 2. November 2025
Englisch
Abmessung: 235mm x 155mm
ISBN-13: 9783032007667
ISBN-10: 3032007666
Artikelnr.: 74737122
Herstellerkennzeichnung
Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
ProductSafety@springernature.com
Autorenporträt
Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of the Universal Scientific Education and Research Network (USERN). Prof. Rezaei supervised more than two hundred research projects and designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He edited more than one hundred international books, presented more than a thousand lectures in congresses/meetings, and published more than 1,500 scientific papers in the international journals.
Inhaltsangabe
Introduction on Cancer Immunotherapy.- Natural Human Immune Response Identifies An Unnatural Oncology Target for Immunotherapy.- Adoptive Immunotherapy Is a Successful Step into Bright Future.- Cancer Immunotherapy Clinical Trials.- Preclinical Cancer Models for the Evaluation of Immunotherapies From Cell Lines to Animal Models.- Immunotherapy and Cancer The Pharmacists Perspective.- Turning Cold into Hot New Insights in Cancer Immunotherapy.- Emerging Trends in Monoclonal Antibody Therapies Targeting Cancer.- Bispecific Antibodies in Targeted Cancer Immunotherapy.- T-Cell Based Therapies Clinical Applications and Challenges.
Introduction on Cancer Immunotherapy.- Natural Human Immune Response Identifies An Unnatural Oncology Target for Immunotherapy.- Adoptive Immunotherapy Is a Successful Step into Bright Future.- Cancer Immunotherapy Clinical Trials.- Preclinical Cancer Models for the Evaluation of Immunotherapies From Cell Lines to Animal Models.- Immunotherapy and Cancer The Pharmacists Perspective.- Turning Cold into Hot New Insights in Cancer Immunotherapy.- Emerging Trends in Monoclonal Antibody Therapies Targeting Cancer.- Bispecific Antibodies in Targeted Cancer Immunotherapy.- T-Cell Based Therapies Clinical Applications and Challenges.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826